MARIANNA DOGOT: Open Payments
NPI 1851476170 · GLEN COVE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,644 in 60 payments from 9 companies in 2025. Trend: 2023 $837 · 2024 $1,583 · 2025 $1,644
Food & beverage: $1,644
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $378 |
| Lundbeck LLC | 19 | $314 |
| Neurocrine BioSciences, Inc. | 5 | $261 |
| Axsome Therapeutics, Inc. | 10 | $231 |
| Otsuka America Pharmaceutical, Inc. | 3 | $162 |
| Teva Pharmaceuticals USA, Inc. | 6 | $115 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Vanda Pharmaceuticals Inc. | 2 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: REXULTI, INGREZZA, ARISTADA, Auvelity, LYBALVI, COBENFY, AUSTEDO XR, HETLIOZ.
Industry payments across NY — which companies pay providers there.
